Updated:
Global Health Innovations
Health Innovation Capital is a venture capital firm investing in pediatric oncology, infectious diseases, and rare/orphan designations. It focuses on unmet...
Global Health Innovations
Health Innovation Capital is a venture capital firm investing in pediatric oncology, infectious diseases, and rare/orphan designations. It focuses on unmet medical needs. The firm targets these areas.
General information
Firm type
Nonprofit
Location
Region
North America
Country
United States
City
Colleyville
Corporate office
Colleyville, TX, United States
Sector focus
Frequently asked questions
Is Global Health Innovations a family office or investment firm?
No. Global Health Innovations is a registered 501(c)(3) nonprofit that designs and manages HIV/AIDS programs in sub-Saharan Africa. It does not operate as a family office, asset manager, or any for-profit investment entity.
What is the HITSystem?
The HITSystem is a technology platform developed by Global Health Innovations that uses internet and SMS text messaging to coordinate care for HIV-exposed infants. It connects healthcare providers, laboratories, and mothers to ensure testing and treatment milestones are met, with the goal of reducing infant mortality.
Where does Global Health Innovations operate?
The organization runs field programs in Kenya, Malawi, Tanzania, and Nigeria. Its administrative headquarters is in Colleyville, Texas, at PO Box 6.
Does Global Health Innovations manage investment capital?
No. Global Health Innovations does not disclose any AUM, portfolio, or investment activity. It is funded through nonprofit sources and focuses on program execution, not capital management.
Who leads Global Health Innovations?
The organization does not publicly name its leadership team. No founder, CEO, or board members are listed on its website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: